Cell fusion method for targeted capturing of CD138 single antibody
A technology of cell fusion and targeted capture, which is applied in the field of biomedicine and can solve problems such as cytotoxicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0012] figure 1 It is a schematic diagram of IgG fusion aiding of the present invention.
[0013] figure 2 is a cell fusion diagram of the present invention.
[0014] exist figure 1 Among them, 1 is myeloma cells expressing CD138, 2 is CD138 monoclonal antibody (IgG), and 3 is B lymphocytes expressing IgGFc receptor. The IgG Ab end of the CD138 monoclonal antibody binds to the CD138 receptor of myeloma cells, while the IgG Fc end binds to the B lymphocytes. Fusion under action.
[0015] exist figure 2 In this method, the fused cells were screened by HAT for 2 weeks, and photographed under an inverted microscope (40X) to obtain hybridoma cell clones.
[0016] Combine below figure 1 and figure 2 , the embodiments of the present invention are described in detail.
[0017] 1. Experimental reagents
[0018] (1) Pre-fusion agent: add 30ng / ml IL-3, 45ng / ml IL-6, 45ng / ml SCF, 3.6μg / L IFN-γ in DMEM medium, which is equivalent to the concentration of fused myeloma cells CD...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com